Terumo Of Japan To Expand Production Lines For Drip-Infusion Products
This article was originally published in PharmAsia News
Executive Summary
Japan's Terumo plans to invest more than $37 million to expand the facilities it uses to make drip-infusion devices. The investment is to cover the cost of installing a new production line of the products that allow drugs to be administered intravenously. A medical-equipment maker, Terumo counted $175 million in sales of the products last year. (Click here for more - a subscription may be required